Showing results (11-20 of 22) with videos related to
Sort By:
Pageof 3
The Cochrane Database of Systematic Reviews|June 22, 2002
LAAM maintenance vs methadone maintenance for heroin dependenceN Clark, N Lintzeris, A Gijsbers, et al.Australian and New Zealand Journal of Public Health|May 19, 2001
Withdrawal from methadone maintenance treatment: prognosis and participant perspectivesM Lenné, N Lintzeris, C Breen, et al.Addictive Behaviors|January 2, 2018
Cognitive, physical, and mental health outcomes between long-term cannabis and tobacco usersM E Lovell, R Bruno, J Johnston, et al.International Journal of Clinical Practice|August 14, 2015
The use of paracetamol (acetaminophen) among a community sample of people with chronic non-cancer pain prescribed opioidsB Hoban, B Larance, N Gisev, et al.BMC Health Services Research|November 8, 2022
Depot buprenorphine as an opioid agonist therapy in New South Wales correctional centres: a costing modelR Ling, B White, J Roberts, et al.Addictive Behaviors|June 24, 2005
A cost-effectiveness analysis of heroin detoxification methods in the Australian National Evaluation of Pharmacotherapies for Opioid Dependence (NEPOD)M D Shanahan, C M Doran, E Digiusto, et al.Scientific Reports|July 7, 2018
Composition and Use of Cannabis Extracts for Childhood Epilepsy in the Australian CommunityA Suraev, N Lintzeris, J Stuart, et al.Scientific Reports|August 3, 2018
Author Correction: Composition and Use of Cannabis Extracts for Childhood Epilepsy in the Australian CommunityA Suraev, N Lintzeris, J Stuart, et al.Drug and Alcohol Dependence|January 16, 2013
A randomised controlled trial of sublingual buprenorphine-naloxone film versus tablets in the management of opioid dependenceN Lintzeris, S Y Leung, A J Dunlop, et al.Health Technology Assessment (Winchester, England)|February 23, 2007
Methadone and buprenorphine for the management of opioid dependence: a systematic review and economic evaluationM Connock, A Juarez-Garcia, S Jowett, et al.Pageof 3